Introduction
Adult-onset Still's disease (AOSD) is a rare systemic inflammatory disorder of unknown aetiology characterized by a typical triad of symptoms including daily high spiking fever, evanescent salmon-pink rash and arthritis/arthralgias. It usually occurs in young people between 16 and 35 years of age [1] ; women are affected slightly more frequently than men [2] [3] [4] . The aetiology of AOSD has not been elucidated, but a combination of genetic and infectious factors in the setting of an immune dysregulation has been suggested with an alteration in cytokine production in favour of a Th1 predominance [5] . IL-18, a proinflammatory and immunoregulatory cytokine, seems to play a pivotal role in promoting the systemic inflammatory process in AOSD [6] , and its serum level is Abstract Purpose: The aim of this study was to assess the clinical and laboratory features of a cohort of Italian patients with adult-onset Still disease (AOSD) with particular attention on possible life-threatening complications. Methods: The clinical charts of 41 consecutive Italian patients with AOSD referred to our rheumatological department over the last 10 years were retrospectively examined. Data regarding clinical manifestations, laboratory features and complications were collected and compared with those reported in literature. Results: The most frequent manifestations were: fever (90.2%), arthralgias (80.4%), skin rash (75.6%), sore throat (53.6%), arthritis (51.2%), lymphadenopathy (48.7%), hepatosplenomegaly (41.4%), myalgia (21.9%), fatigue (12%), diarrhoea and vomiting (9.7%), pleural effusion (9.7%), pericardial effusion (4.8%) and abdominal pain (2.4%). In two patients whose cases are described in detail; the course of the disease was complicated by disseminated intravascuincreased in affected patients correlating with disease activity [7] [8] [9] . Moreover, IL-18 overexpression has been detected in effector target tissues from a variety of autoimmune inflammatory diseases, and we have recently shown that IL-18 is expressed at higher levels in AOSD lymph nodes as compared to nonspecific lymphadenitis and normal lymph nodes [10] .
Several sets of classification criteria have been proposed, the most commonly used being the "Yamaguchi" criteria [11] . However, diagnosis is sometimes challenging, and treatment can be even more difficult. In addition to the classical clinical triad, patients with AOSD can present a constellation of other symptoms, including sore throat, hepatitis, myalgia, serositis, pulmonary manifestations, heart and kidney involvement, abdominal pain, neurological and haematological complications. Moreover, hepatomegaly, splenomegaly and lymphoadenopathy can be seen [12, 13] . Although mortality in AOSD is quite low, a fatal outcome has been reported in some patients [2, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] .
In the present study, we analysed the clinical and laboratory features of an cohort of Italian patients with AOSD and describe in detail two difficult cases, both complicated with disseminated intravascular coagulopathy (DIC), in one case with a fatal outcome.
Patients and methods
The clinical charts of all patients with AOSD (diagnosed according to the Yamaguchi criteria [11] ) referred to the Rheumatology Unit of Sapienza University of Rome over the last 10 years were retrospectively examined. In all patients investigations were carried out in order to rule out infections, malignancies, and other rheumatic diseases. A complete general laboratory work-up, including rheumatoid factor (RF) and antinuclear autoantibodies (ANA), ultrasonography of the abdomen, and chest radiography, was performed in all patients. Joint radiography and ultrasonography, CT scanning, MR imaging, echocardiography, and other specific tests were added if needed on clinical grounds. The clinical manifestations at presentation and the laboratory features were reviewed and recorded using a standardized form for analysis. Disease activity was calculated according to the criteria described by Pouchot et al. in 1991 [14] .
Results
41 patients were considered (23 women/18 men; 21 outpatients/20 hospitalized). The mean age of the patients on 54 Autoimmun Highlights (2010) 1:53-59 admission was 39.5 years (range 18-66 years) and the age at onset ranged from 16 to 64 years (mean 34.8 years).
As expected the most frequent manifestation at the very onset was fever (73%) followed by arthralgia (63.4%), skin rash (46.3%), sore throat (34%) and arthritis (29.2%). However, during follow-up, fever appeared in 37 out of 41 patients (90.2%), arthralgias in 33 (80.4%), skin rash in 31 (75.6%), sore throat in 22 (53.6%), arthritis in 21 (51.2%), myalgia in 9 (21.9%) and fatigue in 5 (12%), Only five patients had abdominal symptoms, four with diarrhoea and vomiting (9.75%) and one with abdominal pain (2.43%). Of the 41 patients, 20 (48.7%) had lymphadenopathy, 17 hepatosplenomegaly (41.4%), 4 pleural effusion (9.75%) and 2 pericardial effusion (4.8%) ( Table 1 ). The classical triad of symptoms (fever, rash and arthritis/arthralgia) was finally found in 28 patients (68.2%). The most commonly affected joints were the hand joints (metacarpophalangeal and proximal interphalangeal) in 19 patients (46.3%), knee in 18 patients (43.9%), wrist in 13 patients (31.7%), ankle in 13 patients (31.7%), foot in 6 patients (14.6%), shoulder in 4 patients (9.7%) and temporomandibular joint in 2 patients (4.8%) ( Table 2) .
ESR was 69.41±28.77 mm/h (mean±SD), and C reactive protein (CRP) was 69.05±78.73 mg/l. Serum ferritin levels were increased above the normal value in 20 patients (48.7%) with a mean value of 5,641.95±8,339.39 ng/ml, being >1,000 ng/ml in 14 patients (34%), >5,000 ng/ml in 8 patients (19.5%) and >8,000 ng/ml in 4 patients (9.7%). Ferritin levels were correlated with disease activity as calculated by Pouchot criteria [14] (Spearman's test, p=0.006). The mean leucocyte count was 18,798.5±7,031 cell/mm 3 (neutrophils 84.64±6.95%), being >10,000/mm 3 in 18 patients (43.9%), >15,000/mm 3 in 13 patients (31.7%) and >18,000/mm 3 in 12 patients (29.2%). Transaminases were twice the normal values in 42.6% of patients (71% considering only patients in an active phase of the disease). In all patients ANA and RF were absent (Table 3) .
All patients were treated orally or intravenously with corticosteroids, in 39.3% of patients in combination with methotrexate (10-15 mg/week), in 25% of patients in combination with cyclosporin A (3-5 mg/kg per day) orally, and in two patients with both. Four patients (9.7%) had disease resistant to the traditional approach and were treated with newer biological drugs with benefit: etanercept in two patients and anakinra in the other two patients [29] .
Case 1
A 34-year-old Caucasian woman presented with a 2-month history of high fever (up to 40ºC), skin rash of the arms and hands, myalgia, wrist arthritis and sore throat. ESR was 95 mm/h, CRP 341 mg/l, WBC 35,900/mm 3 , AST 101 U/l and ALT 113 U/l. Serum ferritin was markedly elevated at 23,849 ng/ml. She was initially hospitalized in the Department of Infectious Disease where an extensive work-up (including HIV, HBV and HCV, CMV, EBV, Salmonella, Brucella, and blood, urine and stool cultures) was negative. Transthoracic echocardiography was normal. A total body CT scan revealed diffuse lymphoadenomegaly, splenomegaly, hepatomegaly and a small amount of bilateral pleural effusion. On the hypothesis of AOSD, prednisolone 40 mg was started with no 55 Autoimmun Highlights (2010) 1:53-59 amelioration of symptoms. The patient was moved to our department for further evaluation.
On admission the patient was spikingly febrile (up to 40°C) and the spikes were always associated with the typical skin rash on the arms, legs, trunk and face. Arthritis of both wrists was still present. High-dose intravenous methylprednisolone was started (250 mg daily) with only a partial improvement of arthritis. During the second day of hospitalization, she showed hypotension (blood pressure 80/50 mmHg), severe dyspnoea, and oliguria. Her WBC was 29,000/mm 3 , haemoglobin decreased to 10 g/dl, platelets decreased to 79,000/mm 3 , INR was 2.36, fibrinogen was 150 mg/dl, and antithrombin III was decreased (49%). A smear of peripheral venous blood excluded a macrophage activation syndrome. Her condition rapidly deteriorated with the progressive development of DIC. The patient was treated with fresh frozen plasma, antithrombin III and dexamethasone, and was then admitted to the intensive care unit where she died a few hours later.
Autopsy showed severe myocarditis ( Fig. 1) , serofibrinous pericarditis, confluent foci of pneumonic infil- Later, because of a rapid worsening of haemodynamic condition, she was admitted to the intensive care unit where transthoracic echocardiography demonstrated a global severe hypokinesia of the myocardium. High-frequency atrial fibrillation developed. The patient underwent electrical cardioversion and a mechanical intraaortic balloon counterpulsation was introduced. Cardiac MR imaging showed a subacute myocarditis. Intravenous methylprednisolone 250 mg was started. The patient gradually improved and the corticosteroid was tapered. Over the subsequent months, the patient experienced a relapse of fever, arthritis and rash whenever steroid treatment was reduced. Methotrexate 15 mg weekly was prescribed with benefit, and at the time of this report the patient was still in complete remission without corticosteroid.
Discussion
The prevalence of AOSD seems to be low in Italy, and only one large cohort of italian patients has been very recently published [28] . In Japan, the prevalence among men and women over the age of 16 years has been estimated to be 0.73/100,000 and 1.47/100,000, while the crude incidence rates are 0.22 and 0.34, respectively [30] . The yearly incidence in the Caucasian population seems to be lower [31] . Description of cases from several countries is important as inflammatory diseases often have different clinical expressions in people of different ethnicities, and also in AOSD the clinical presentation in Western countries is slightly different from that in Eastern countries [28, [32] [33] [34] .
The clinical triad of symptoms typical of AOSD (fever, joint involvement and skin rash) was frequently present in our population and, as expected, fever was the predominant feature (Table 1) . Actually, AOSD is one of 56 Autoimmun Highlights (2010) 1: [53] [54] [55] [56] [57] [58] [59] trates and areas of atelectasia, serofibrinous bilateral pleuritis, diffuse subpleural petechiae and subendothelial bleeding in the gastric mucosa, and hyperplasia of the spleen and of the inguinal and axillary lymph nodes. We had the opportunity to measure the serum IL-18 level with a commercial ELISA kit (Immuno Pharmacology Research, Italy), and detected a very high value (1,236.9 pg/ml) in comparison to 189 pg/ml (range 0-144 pg/ml) in the serum from 21 healthy blood donors.
Case 2
A 42-year-old Caucasian woman presented with an erythematous transitory skin rash localized mainly on her face, arthralgia involving the wrists and knees, sore throat and spiking fever up to 39ºC. ESR was 27 mm/h, CRP was 173.5 mg/l WBC was 19,620/mm 3 and ferritin was the possible causes of long-standing fever of unknown origin. Joint involvement was present in the majority of patients in the form of diffuse arthralgia, while arthritis appeared in only half of the patients. The hand was slightly more frequently impaired than the knee, which has been reported as the joint primarily affected in AOSD [14, 35] (Table 2) . Erosions were not detected and serum RF was always absent. In two patients with severe joint involvement resistant to conventional treatment, administration of the IL-1 receptor antagonist anakinra resulted in sustained remission. In these patients, the benefit of IL-1 blockade on arthritis was confirmed by musculoskeletal ultrasonography [29] . Skin rash was the third most prevalent symptom (Fig. 2) , usually appearing during the feverish attack and generally responding to steroid treatment.
A significant neutrophilic leucocytosis associated with an increase in ESR, CRP and ferritin values are almost invariably detected in patients with active AOSD, and this finding was confirmed in our cohort. Hyperferritinaemia seems to be the main feature of AOSD in which it can reach very high concentrations especially in those patients with reactive haemophagocytosis syndrome. In our survey, very high ferritin values (>5,000 ng/ml) were found in 20% of the patients, and its concentration was significantly correlated with disease activity.
An increase in hepatic enzymes was recorded in almost three-quarters of our patients with active AOSD. This finding is in line with the findings of other studies in which liver involvement has been found in 40-90% of patients [14, 18, 36] . The mild hepatitis found in AOSD is often characterized by moderate abnormalities in liver biochemistry, such as elevation in transaminases and cholestasis, while, more rarely, severe cytolysis and subsequent death occur [14, 16-18, 23, 24] in accordance with the observation in our cohort where no patient showed hepatic failure. Severe liver involvement can occasionally be related to the concomitant use of potential hepatotoxic drugs such as sulphasalazine, NSAIDs, aspirin and cyclosporine [14, 16, 23, [37] [38] [39] [40] [41] .
In the present cohort, 5% of patients (2/41) experienced life-threatening complications such as DIC, adult respiratory distress syndrome (ARDS) and heart involvement requiring intensive care. As far as we know, 16 fatalities have been reported among the largest eleven cohorts including 618 patients with AOSD published so far (mortality 2.6%, range, 0-9.83%) [2, 14-18, 28, 35, 42, 43, 44] .
Establishing the precise, final cause of death is not always possible as the patient may finally present a multiorgan failure which can be difficult to differentiate from a septic state. DIC is one of the most dramatic events in AOSD and is a possible cause of death [2, 18, 20, 22, 28] although complete recovery in several patients has been reported [2, 14, 22, 35, 42, [45] [46] [47] [48] [49] [50] . It can follow or be associated with reactive haematophagocytic syndrome (RHS), a further possible life-threatening complication in AODS [15, 17, 21, 22, 43, 51] . This event is characterized by an uncontrolled and sustained activation of macrophages associated with impairment of cytotoxic function with a true cytokine storm [22] . Leucopoenia, thrombocytopenia, hypertriglyceridaemia and very high ferritin values can be considered as red flags for RHS although there is no established set of criteria for its diagnosis in adults. In the two patients whose cases are described in detail, RHS was excluded because of significant leucocytosis and no increase in triglycerides, and a completely normal peripheral blood smear, although bone marrow aspiration, which is considered a sensitive diagnostic procedure for RHS, was not performed. Arlet et al. [22] recently described six patients with AOSD and associated RHS, one with a fatal outcome, suggesting that RHS may go under-diagnosed in AOSD. Some authors have proposed that AOSD, its paediatric variant systemic onset juvenile idiopathic arthritis (SoJIA) and RHS are indeed the same disease in different clinical presentations but with essentially the same physiopathogenesis [52] .
The autopsy performed in the patient who died demonstrated multiorgan involvement with clear evidence of myopericarditis and lung involvement. The patient was 57 Autoimmun Highlights (2010) 1:53-59 dyspnoeic and hypoxic and showed multiple pulmonary infiltrates as is seen in ARDS. Three other cases of fatal AOSD and ARDS have been described in one case associated with RHS [22, 25, 26] . Myocarditis [14, 16, 20, 35, 46, [53] [54] [55] , and in particular cardiac tamponade [45] , can also very rarely complicate the course of AOSD, more frequently appearing in the paediatric form. Indeed, in SoJIA, myocarditis is a well-known complication often associated with pericardial effusion, which can lead to congestive heart failure and arrhythmias. In AOSD heart involvement is generally represented by chronic myocarditis, leading to progressive dilatation and subsequent heart failure. In the first case presented above, the diagnosis of myocarditis was histologically confirmed post mortem while in the second case the diagnosis was made on clinical grounds and the patient responded to high-dose corticosteroids as previously described [54, 56] . High-dose intravenous immunoglobulin therapy may also be useful in acute Still's myocarditis [57] , but evidence is still inconclusive [58] .
Other possibly fatal complications, such as thrombotic thrombocytopoenic purpura [59] , haemolytic uraemic syndrome [60] , and neurological complications such as aseptic meningoencephalitis [2, 61] , neuropathy [14, 16, 62] and status epilepticus [19] , have been described in AOSD, but were not detected in our cohort.
In conclusion, we have described the phenotype of AOSD in a large Italian cohort of patients with particular attention on possible life-threatening complications that may occur during the course of the disease.
Although the prognosis of AOSD is generally considered favourable, the present report suggests that the disease represents a troubling condition needing prompt intervention and the use of biological drugs in some selected patients with refractory disease. Occasionally, AOSD may rapidly worsen with life-threatening events. Although these complications are rather rare, early identification is of the utmost importance in order to halt evolution of the disease and prevent a possible fatal outcome.
